Combining Radiotherapy With Anti-angiogenic Therapy and Immunotherapy; A Therapeutic Triad for Cancer?
Radiotherapy has been used for the treatment of cancer for over a century. Throughout this period, the therapeutic benefit of radiotherapy has continuously progressed due to technical developments and increased insight in the biological mechanisms underlying the cellular responses to irradiation. In...
Main Authors: | Ruben S. A. Goedegebuure, Leonie K. de Klerk, Adam J. Bass, Sarah Derks, Victor L. J. L. Thijssen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2018.03107/full |
Similar Items
-
Metabolic and hypoxic adaptation to anti‐angiogenic therapy: a target for induced essentiality
by: Alan McIntyre, et al.
Published: (2015-02-01) -
Radiotherapy and Antiangiogenic TM in Lung Cancer
by: Mohamed K. Khan, et al.
Published: (2002-01-01) -
Immune checkpoint and angiogenic inhibitors for the treatment of hepatocellular carcinoma: It takes two to tangle
by: Caecilia Sukowati, et al.
Published: (2022-09-01) -
Research Progress on Radiotherapy Combined with Immunotherapy for Associated Pneumonitis During Treatment of Non-Small Cell Lung Cancer
by: Zhang A, et al.
Published: (2022-08-01) -
Challenges in synergizing radiotherapy with immunotherapy to unlock the abscopal effect in metastatic NSCLC: A systematic review
by: Jason Liu, et al.
Published: (2023-09-01)